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Abstract
Background: Venous Thromboembolism (VTE) is the most common complication following major joint surgery.
While attention has been focused upon the incidence of thromboembolic disease following total hip or knee
arthroplasty or emergency surgery for hip fracture, there exists a gap in the medical literature examining the
incidence of VTE in spinal surgery. Evidence suggests that the prevalence of DVT after spinal surgery is higher than
generally recognized but with a shortage of epidemiological data, guidelines for optimal prophylaxis are limited.
This survey, of individuals attending the 2009 British Association of Spinal Surgeons Annual Meeting, sought to
examine prevailing trends in VTE thromboprophylaxis in spinal surgery, adherence to guideline outlined by the
National Institute for Health and Clinical Excellence (NICE) and to compare selections made by orthopaedic and
neurosurgeons.
Methods: We developed a questionnaire with eight clinical scenarios. Participants were asked to supply details on
their specialty and to select which method(s) of thromboprophylaxis they would employ for each scenario. Chi
squared analysis was used for statistical comparison of the questionnaire responses.
Results: 73% of neurosurgical respondents’ and 31% of orthopaedic surgeons employed low molecular weight
heparin (p < 0.001). Neurosurgeons also selected anti-embolism stockings more frequently (79% v 50%) while
orthopaedic surgeons preferred mechanical prophylaxis (26% v 9%). There was no significant difference between
trauma and non-trauma scenarios (p = 0.05).
Conclusion: There is no clear consensus in thromboprophylaxis in spinal surgery. There was a significant difference
in selections across surgical disciplines with neurosurgeons more closely adhering to national guidelines. Further
research examining the epidemiology of venous thromboembolism in spinal surgery and the risks-benefit
relationship of thromboprophylaxis is warranted.
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Introduction
With an incidence estimated between 2.9% and 3.7%,
venous thromboembolism (VTE) is the most common
complication following major joint surgery [1]. Manifest-
ing as deep vein thrombosis (DVT) or pulmonary embo-
lism (PE), VTE is a leading cause of medical morbidity
and mortality. In the United States it represents the
third most common cause of death after myocardial
infarction and stroke [2]; in Europe it is responsible for
an estimated 540,000 deaths each year [3].
While considerable attention has been focused upon
thromboembolic disease following total hip or knee
arthroplasty or emergency surgery for hip fracture, their
exists a gap in the medical literature examining the inci-
dence and implications of VTE in spinal surgery [4].
Studies suggests that the prevalence of DVT after spinal
surgery is higher than generally recognised with veno-
graphic evidence of DVT detected in 15.5% of patients
following posterior spinal surgery where no thrombo-
prophylaxis was used [5]. In patients who have suffered
major trauma and spinal cord injury the incidence of
calf DVT may be as high as 40-80% [6]. With a shortage
of epidemiological data, guidelines for optimal prophy-
laxis were once limited. At the time of this study the
National Institute for Health and Clinical Excellence
(NICE) guidance on VTE prophylaxis, Reducing the risk
of venous thromboembolism (deep vein thrombosis and
pulmonary embolism) in patients undergoing surgery,
recommended mechanical prophylaxis with graduated
compression stockings, intermittent pneumatic
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prophylactic measures for low-risk patients undergoing
neurological surgical procedures (including spinal sur-
gery). For individuals with one or more patient related
risk factors (Table 1) mechanical prophylaxis and
LMWH was advised, though the latter was to be
avoided in cases of ruptured cranial or spinal vascular
malformations where the lesion had not been secured
[7]. While guidance existed, in the absence of sufficient
data [4] surgical practitioners were granted some lati-
tude and advised to exercise clinical judgment and con-
sider individual patient history when selecting and
employing VTE prophylaxis.
In the absence of an ideal prophylactic regime for
spinal surgery and given the scope for selection of pro-
phylactic agents based upon individual preferences, we
undertook a survey of surgeons attending the 2009 Brit-
ish Association of Spinal Surgeons (BASS) Annual Meet-
ing in an attempt to: 1) examine prevailing trends in VTE
thromboprophylaxis in spinal surgery, 2) assess adher-
ence to guidelines outlined by NICE and 3) compare
selections made by orthopaedic surgeons and neurosur-
geons and between trauma and non-trauma scenarios.
BASS is the specialist society representing spinal sur-
geons in the UK. It has more than four hundred mem-
bers who are Consultants or surgeons in training with a
specific declared interest in spinal surgery. Approxi-
mately two-thirds of BASS members are orthopaedic
surgeons and one-third neurosurgeons.
Methods
We developed a questionnaire based on eight clinical
scenarios–two emergency procedures, two elective pro-
cedures and four trauma cases.
Emergency
1. 44 year old woman with a BMI of 38 undergoing dis-
cectomy for Cauda Equina Syndrome (CES)
2. 65 year old man undergoing posterior decompres-
sion and instrumented fusion of T7-L1 for spinal cord
compression from metastatic bone disease of prostatic
origin
Elective
1. 33 year old man undergoing L5-S1 discectomy
2. 72 year old woman with diabetes mellitus and
hypertension undergoing L2-L5 lumbar decompression
for spinal stenosis
Trauma
1. 24 year old man undergoing posterior stabilisation of
a burst fracture of L1
2. 36 year old woman undergoing anterior cervical
decompression and fusion for a unifacetal fracture
subluxation
3. 18 year old woman with a bony chance fracture of
T12 treated conservatively with 6 weeks bed rest fol-
lowed by 6 weeks in a brace
4. 52 year old Asian man with TB with spinal cord
compression treated with a 2-stage procedure–an ante-
rior vertebrectomy of T6 and a posterior instrumented
fusion of T4-T8 one week later.
Participants were asked to supply details of their area
of specialty (orthopaedics or neurosurgery) and to select
which method(s) of thromboprophylaxis they would
employ for each scenario. Six methods of VTE preven-
tion were provided:
￿ Warfarin
￿ Low Molecular Weight Heparin (LMWH)
Table 1 Risk Factors for Venous Thromboembolism as outlined by NICE
General factors increasing the risk of VTE Patient related risk factors
￿ Surgical procedure with a total anaesthetic time of more than 90
minutes, or 60 minutes if the surgery involves the pelvis or lower limb
￿ Active cancer or cancer treatment
￿ Acute surgical admission with inflammatory or intra-abdominal
condition
￿ Age over 60 years
￿ Expected significant reduction in mobility ￿ Critical care admission
￿ One or more of the patient related risk factors outlined to the right. ￿ Dehydration
￿ Known Thrombophilias
￿ Obesity (BMI > 30 kg/m
2)
￿ One or more significant medical comorbidities (heart disease, metabolic,
endocrine or respiratory pathologies, acute infectious diseases or
inflammatory pathologies
￿ Personal history or a first degree
relative with a history of VTE
￿ Use of hormone replacement therapy
￿ Use of oestrogen-containing contraceptive therapy
￿ Varicose veins with phlebitis
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￿ Below Knee Thromboembolic Deterrent Stockings
(BK TEDS)
￿ None/Early Mobilisation
￿ Mechanical prophylaxis
Chi squared analysis was used for statistical compari-
son of the questionnaire responses. P < 0.05 constituted
a statistically significant result.
Results
We distributed 50 questionnaires at the 2009 BASS
Annual Meeting. Participants were asked to select which
method(s) of venous thromboprophylaxis they would
choose to employ for each scenario. The number of
selections of each prophylactic method was summated
and percentage selection determined. The response rate
varied across clinical scenarios but on average the
response from orthopaedic surgeons was twice that of
neurosurgeons, reflecting the proportional representa-
tion at the conference. Table 2 illustrates the responses
across surgical disciplines and the frequency of throm-
boprophylaxis selection.
Aspirin and warfarin were selected so infrequently
(total number of selections for aspirin = 9; warfarin = 1)
that their numbers proved insignificant and were subse-
quently discarded from statistical analysis.
There were clear differences in thromboprophylaxis
selection between surgical disciplines. Overall, neurosur-
geons preferred low molecular weight heparin (LMWH)
compared with orthopaedic surgeons; 73% of neurosur-
gical respondents’ preferences included LMWH com-
pared to 31% of orthopaedic regimens (p < 0.001).
Below Knee thromboembolic deterrent stockings (BK
TEDS) more frequently (79% v 50% for neurosurgeons
and orthopaedic surgeons respectively). In contrast,
o r t h o p a e d i cs u r g e o n sw e r em o r ei n c l i n e dt os e l e c t
mechanical thromboprophylaxis than their neurosurgical
counterparts (26% v 9% respectively) (Table 3).
Table 4 shows the frequency of the different modes of
thromboprophylaxis selected for the trauma scenarios
compared with those of the elective and emergency
cases. There was no significant difference in VTE pro-
phylaxis selection between the two groups; 53% of
thromboprophylaxis plans advocated the use of LMWH
in trauma cases. This figure fell to 39% for the non-
trauma scenarios. The difference did not reach statistical
significance.
Discussion
Venous thromboembolism is amongst the most feared
post-operative complications. Orthopaedic patients are
at significant risk for thrombolic events [8] and along
with signs of wound infection, post-operative orthopae-
dic patients are scrutinised daily for clinical and
symptomatic evidence of VTE. In an attempt to mini-
mise the risk of these adverse complications, elective
and trauma patients are routinely prescribed pharmaco-
logical anticoagulant therapies, often at the time of
admission and frequently without a full VTE risk assess-
ment, because local policies dictate that such patients
should be the recipient of these agents. This pre-emp-
tive prescription of VTE prophylaxis does not extend to
the realm of spinal surgery. Rather, spinal surgeons have
traditionally expressed concern and hesitancy over the
use of anticoagulation in spinal surgery. While the inci-
dence of VTE in elective spinal surgical patients appears
to be lower than that seen in patients undergoing major
surgery on the lower limb [9], the potential for deleter-
ious complications is considerably greater–the risk of
haemorrhagic complications including spinal epidural
haematoma and cauda equina syndrome [4,8] increase
with the administration of anticoagulation therapy.
Thus, the risk of potential complications of VTE pro-
phylaxis must be weighed against the risk of throm-
boembolism itself.
In January 2010, NICE published updated guidance on
VTE prophylaxis–CG92 Reducing the risk of venous
thromboembolism in patients admitted to hospital.
These guidelines advise that surgical practitioners
should offer VTE prophylaxis to patients undergoing
cranial or spinal surgery (commonly combined and
entitled neurosurgery) who are deemed to be at an
increased risk of VTE (Table 1). Based upon this gui-
dance, patients should receive mechanical VTE prophy-
laxis with anti-embolism stockings, intermittent
pneumatic compression devices, or foot impulse devices
at the time of admission, with pharmacological VTE
prophylaxis to be added in patients with a low risk of
major bleeding. Clinicians are further advised to take
into account individual patient factors and to exercise
clinical judgment when electing to employ LMWH or
Unfractionated Heparin (UFH, for use in patients with
renal failure). Mechanical and pharmacological prophy-
laxis should remain in place for the duration that mobi-
lity is significantly reduced [9].
For patients with spinal injury, NICE recommends
mechanical prophylaxis (as for those undergoing cranial
or spinal surgery) and if the benefits of reducing the risk
of VTE outweigh the risks of bleeding, patients should
also receive pharmacological VTE prophylaxis in the
form of LMWH or UFH. The 2010 guidance also out-
lines a number of criteria which, if met, should prompt
clinicians to regard such patients as being at increased
risk of VTE [9] (Table 1).
The American College of Chest Physicians (ACCP)
has also published guidance on VTE prophylaxis in sur-
gery. For patients without risk factors for VTE who are
undergoing elective spinal surgery, the ACCP advises
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Scenario (number of respondents) Frequency of Thromboprophylaxis selection
Warfarin LMWH Aspirin BK Teds None/EM Mechanical
Emergency 1:
Orthopaedics (18) 06 0 1 0 9 7
Neurosurgery (9) 07 08 3 1
Speciality unknown (12) 06 18 5 0
Emergency 2:
Orthopaedics (18) 08 0 1 0 6 4
Neurosurgery (9) 08 07 2 1
Speciality unknown (12) 06 18 4 1
Elective 1:
Orthopaedics (18) 00 09 1 5 4
Neurosurgery (9) 02 06 6 1
Speciality unknown (12) 01 15 8 0
Elective 2:
Orthopaedics (18) 05 1 1 0 9 5
Neurosurgery (9) 07 17 2 1
Speciality unknown (12) 05 17 3 0
Trauma 1
Orthopaedics (18) 05 09 9 6
Neurosurgery (9) 05 08 3 1
Speciality unknown (12) 06 15 2 0
Trauma 2
Orthopaedics (19) 02 07 1 3 5
Neurosurgery (8) 05 07 3 1
Speciality unknown (10) 03 03 6 0
Total response (37)
Trauma 3
Orthopaedics (18) 11 1 1 8 3 2
Neurosurgery (9) 09 06 1 0
Speciality unknown (10) 09 14 1 0
Trauma 4
Orthopaedics (19) 08 0 1 1 6 5
Neurosurgery (8) 08 06 1 0
Speciality unknown (9) 09 03 1 0
Table 3 Thromboprophylactic selections for orthopaedics
and neurosurgery
Orthopaedics v Neurosurgery:% selection
Method of Thromboprophylaxis Orthopaedics Neurosurgery
LMWH 31% 73%
BK TEDs 50% 79%
None/Early Mobilisation 48% 30%
Mechanical 26% 9%
p = < 0.001
Table 4 Percent thromboprophylaxis selections for
trauma and non-trauma scenarios
% VTE Selection: Trauma v Non-trauma scenarios
Method of Thromboprophylaxis Trauma Non-trauma
LMWH 53% 39%
BK TEDs 52% 59%
None/Early Mobilisation 33% 46%
Mechanical 13% 16%
p = 0.05
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with additional risk factors such as advanced age,
known malignancy, neurological deficit previous DVT or
anterior spinal approach, some form of prophylaxis is
advised–be it mechanical (with graduated compression
stockings or IPC) or pharmacological (LMWH or low-
dose unfractionated heparin). For those with risk factors
beyond those listed above, post-operative LDUH or
LMWH or perioperative IPC alone may be considered.
In patients with multiple risk factors a combination of
LDUH or LMWH and graduated compression stockings
or IPC is recommended. Similarly, for those with acute
spinal cord injury, thromboprophylaxis is recommended
for all patients–this may take the form of LMWH once
primary haemostasis is achieved and IPC or graduated
compression stockings when pharmacological prophy-
laxis is contraindicated [10].
The recommendations outlined by the ACCP were not
met with universal acceptance. Rather, such was the
consternation amongst North American orthopaedic
surgeons that the American Academy of Orthopaedic
Surgeons (AAOS) published its own guidance on VTE
prophylaxis for patients undergoing total hip and knee
arthroplasty [11]. British orthopaedic surgeons expressed
similar concerns over the appropriateness of the 2007
NICE guidance on VTE prophylaxis in orthopaedic
practice [11]. In response to such discord, seven ortho-
paedic surgeons, a patient representative from the BOA
and nurse specialist in VTE were selected to form an
advisory panel to work with NICE on the establishment
of the current VTE guidelines of January 2010 [11].
While the guidance issued by the ACCP seeks to
cover all eventualities and potential scenarios, the 2010
NICE recommendations, though structured, are not as
didactic and instead afford surgeons some latitude in
their thromboprophylaxis strategies. Observing the gui-
dance issued by NICE–both the 2007 and 2010 guide-
lines–one could argue that thromboprophylaxis with
LMWH should be employed in seven of the eight sce-
narios used in this survey. The recommended thrombo-
prophylactic regimes for each scenario, and the
justification for these selections are outlined in Table 5.
While there are strong indications for pharmacological
thromboprophylaxis (with LMWH) in seven of the eight
clinical scenarios (87.5%), participant selection does not
reflect this. This is particularly so amongst orthopaedic
surgeons where 31% of thromboprophylaxis regimens
included LMWH; in contrast, neurosurgical respondents
elected to employ LMWH more than twice as often–
73% of the time.
A similar theme was noted in the selection of
mechanical prophylaxis. The NICE guidelines advocate
Table 5 Clinical scenarios employed in questionnaires with thromboprophylaxis regimens advocated by NICE and
pertinent points of consideration
Patient Diagnosis Procedure Prophylaxis Justification for pharmacological therapy
Emergency
44 female
BMI 38
Cauda Equina Discectomy TED
LMWH
IPC
Raised BMI
65 male Metastatic Ca Posterior stabilisation T7-L1 TED
LMWH
IPC
Active malignancy
Elective
33 male Disc Prolapse L5/S1 Discectomy TEDs
IPC
May consider LMWH if surgery/anaesthetic
duration > 90 min
72 female,
DM & HTN
Spinal Canal stenosis L2-L5 lumbar decompression TEDs
IPC
LMWH
Medical co-morbidities
Trauma
24 male Burst L1 Posterior Stabilisation TEDs
IPC
LMWH
May consider LMWH if duration of anaesthetic/
surgery > 90 min
36 female Unifacetal fracture
subluxation
Decompression and fusion TEDs
IPC
LMWH
May consider LMWH duration of anaesthetic/
surgery > 90 min add LMWH
18 female Boney Chance # 6 weeks bed rest 6 weeks brace TEDs
IPC
LMWH
Prolonged immobility
52 male TB and spinal cord
compression
Anterior vertebrectomy T6; posterior
instrumentation T4-T8 one wk later
TEDs
IPC
LMWH
Acute infectious diseases or inflammatory
condition
Bryson et al. Journal of Orthopaedic Surgery and Research 2012, 7:14
http://www.josr-online.com/content/7/1/14
Page 5 of 8the use of mechanical prophylaxis (anti-embolism stock-
ings, intermittent pneumatic compression devices, or
foot impulse devices) for all patients with spinal injury
and those undergoing cranial or spinal surgery. The use
of BK TEDs and mechanical devices would be indicated
in all the scenarios used in this survey and neurosurgical
respondents were again more compliant with the guide-
lines electing to employ BK TEDs 79% of the time while
frequency of selection fell to 50% for orthopaedic sur-
geons. However, these roles were reversed for mechani-
cal prophylaxis which featured in the
thromboprophylactic regimes 26% of the time for ortho-
paedic surgeons and 9% of the time for neurosurgeons.
The presence or absence of trauma did not signifi-
cantly influence participants’ responses. Trauma
increases the risk of VTE by inducing a hypercoagulable
state and in the absence of thromboprophylaxis veno-
graphic studies reveal calf DVT rates as high as 40% to
80% in patients suffering major trauma [4]. NICE advo-
cates the use of mechanical prophylaxis with pharmaco-
logical therapy used as an adjunct in cases where the
benefits of VTE reduction outweigh the risks of bleed-
ing. As touched upon above, NICE further advises that
practitioners regard surgical and trauma patients as high
risk for VTE if they meet one of the patient-related risk
factors criteria outlined in Table 1. The results of this
survey did not reveal any significant difference in VTE
prophylaxis between trauma and non-trauma scenarios.
Traditionally clinicians have cited a shortage of high-
quality evidence-based recommendations [6] and the
inherent variability in the nature of spinal surgery [4] as
rationale for deviation from standardized thrombopro-
phylaxis regimes with reliance instead upon individual
preferences and patient specific factors. The orthopaedic
surgical panel convened to liaise with NICE acknowl-
edged such shortcomings in available data citing a ‘lim-
itation in the availability of clinically important and
relevant outcomes to guide the formation of suitable
recommendations’ [11]. It is perhaps because of this
persisting gap that NICE repeatedly acknowledges the
need for surgeons to exercise clinical judgment, to take
into consideration patient specific factors, to regularly
reassess VTE risk and risk of bleeding and ultimately
recommends that patients should be ‘offered’ VTE pro-
phylaxis where it is deemed appropriate.
Conclusion
The results of this study revealed significant discrepan-
cies in VTE prophylaxis selection between the surgical
specialties surveyed. Neurosurgeons appear to adhere
more closely to guidance outlined by NICE than their
orthopaedic counterparts. Quite why this should be the
case is unclear and beyond the scope of this survey.
Moreover, any attempt to explain or theorise why this
discrepancy exists would be but conjecture.
We readily acknowledge that the small numbers sur-
veyed and the disparity in number between the groups
surveyed limits the extent to which these outcomes can
be extrapolated. Similarly, we recognise the inherent
limitations of this study and the potential bias, including
underrepresentation, voluntary response and non-
response bias, associated with a survey. However, the
outcome of this study is in keeping with similar, though
admittedly more robust, surveys including that con-
ducted by Ploumis et al. who attempted to determine a
basis for a consensus protocol on thromboprophylaxis
in spinal surgery and trauma in the United States. After
surveying 47 spinal surgeons (neurosurgical and ortho-
paedic) from the Spinal Trauma Study Group, Ploumis
and colleagues could find no consensus on the preferred
method of medical thromboprophylaxis or on thrombo-
prophylaxis selections for 3 spinal trauma case scenarios
[6]. Clearly these results and conclusions are not wholly
transferable–their study could find no agreement on the
method of chemical thromboprophylaxis–rather, it illus-
trates the point that discrepancies and uncertainties per-
sist, both in the United States and the United Kingdom
and that variations can be seen between, and indeed
within, surgical disciplines.
This uncertainty has been attributed, in large part, to
a paucity of literature examining VTE in spinal surgery
[12,13]. Moreover, the scientific evidence that exists is
based on level III studies rather than level I randomised
controlled trials [14]. In a 1997 review of thromboem-
bolic complications and the effects of thromboprophy-
laxis in elective spinal surgery surgery, MG Catre
reported an absence of statistically strong research
examining the true incidence of thromboembolic com-
plications in spinal surgery [15]. Catre concluded that a
well-designed, randomized controlled study to define
the efficacy of thromboprophylaxis in elective spinal sur-
gery would be needed before recommendations for
thromboprophylactic regimes could be made [15].
Despite considerable attention in the years that have fol-
lowed, uncertainty prevails. The incidence of VTE in
spinal surgery, the most appropriate regime and timing
of thromboprophylaxis in spinal surgery remains a mat-
ter of debate.
Literature chronicling the incidence of thromboem-
bolic complications following spinal surgery is varied. In
2001 Geerts et al. reported that the incidence of throm-
boembolic complications following elective spine surgery
was unknown [16]. In 2004 Giancarlo Agnelli placed the
rate of clinically overt DVT and PE in elective spinal
patients at 3.7% and 2.2% respectively [17], while Roktio
et al. reported an incidence of 0.3% following
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estimated the incidence at between 0.9% and 14% [18].
Oda et al. identified venographic evidence of DVT in
15.5% of patients following posterior spinal surgery
where no thromboprophylaxis (chemical or mechanical)
was used [5], while Cheng et al., in a systematic review
of anticoagulation risk in spine surgery, cite a risk of
venous thromboembolism in patients not receiving che-
mical thromboprophylaxis of 2.3% in surgery for degen-
erative conditions, 5.3% for procedures to correct
deformity and 6.0% for trauma patients [12].
In patients undergoing elective neurosurgical proce-
dures, where the risk of DVT and PE are known to be
higher [16], the incidence of overall DVT and proximal
DVT in a double-blind, randomized, venography-based
trial was identified at 26% and 12% respectively in
patients receiving thrombembolic stockings. These fig-
ures fell to 19% and 7% in those treated with stockings
and LMWH [17]. The sequelae associated with throm-
boembolic complications appears equally varied; accord-
ing to Cheng et al., fatal pulmonary embolism is rare
[12] but Angelli et al., cite an incidence of pulmonary
embolism in neurosurgical patients of between 1.5% and
5% with a mortality of 9% to 50% [19]. In trauma
patients and those with acute spinal cord injury (SCI)
the risk of thromboembolic complications is greater
than the elective realm–so much so that acute SCI
patients have the highest risk of DVT among all hospital
admissions [16]. In patients who have suffered major
trauma and spinal cord injury the incidence of calf DVT
may be as high as 40-80% [6] and fatal PE is the third
most common cause of death in this cohort of patients
[16].
The risk of thromboembolism must therefore be
weighed against the potentially catastrophic effects of
bleeding, haematoma formation and neurological deficit
[4]. Because chemical anticoagulation has not gain wide-
spread acceptance by spinal surgeons [4], largely driven
by fear of the complications outlined above, the true
incidence of bleeding complications is unclear. In an
examination of the efficacy and safety of LMWH as pro-
phylaxis against VTE in patients undergoing elective
neurosurgery, Agnelli et al., found no increase in the
risk of intracranial bleeding with the use of enoxaparin.
Of the 307 patients who underwent neurosurgical pro-
cedures (including surgery for brain or spinal tumours,
cerebral aneurysms, vertebral disc displacement and
gliosis), three patients in the enoxaparin cohort and four
patients in the placebo group suffered major intracranial
bleeding [19]. In contrast, the combination of LMWH
and compression stockings nearly halved the rate of
venous thromboembolism [19]. These findings are in
keeping results reported by Gerlach et al., who found
that post-operative chemical thromboprophylaxis with
LMWH (nadroparin) was not associated with an
increased risk of post-operative haemorrhage [20]. In a
cohort of 1,954 patients who underwent spinal surgery
over a 3-year period, 8 procedures (0.4%) were compli-
cated by major post-operative haemorrhage following
the administration of LMWH [20]. However, other
authors put the risk higher by a factor of 10 with com-
plications of bleeding reportedly occurring in up to 4%
of patients [21].
This uncertainty is reflected in the results of an email
survey conducted by Globtzeker et al. assessing practices
for thromboprophylaxis in cases of high-risk surgery for
tumours and trauma. As was the case with our survey
and the results elucidated by Polumis and colleagues,
Glotzbecker et al. identified startling variability amongst
the ninety-four orthopaedic and neurosurgical partici-
pants; 29% of those surveyed felt the risk of post-opera-
tive epidural haematoma was less than 1%, 47% selected
a risk of between 1% and 5%, and 17% felt that may rise
as high as 5%-10% [13]. Regarding estimates for the
most appropriate timing for thromboprophylaxis, 15%
reported they would institute chemical thromboprophy-
laxis 24 hours after surgery, 22% stated they would com-
mence thromboprophylaxis after 48 hours, 13% selected
72 hours, 10% chose 96 hours, and 12% reported they
would commence therapy within 24 hours [13].
The one area where consensus and uniformity can be
found is in the recognition of the need for further
research examining thromboembolic complications and
thromboprophylaxis in spinal surgery. Venous throm-
boembolism is a leading cause of medical morbidity and
m o r t a l i t y[ 1 - 3 ] .I ns p i n a ls u r g e r y ,m o r es ot h a ni np e r -
haps any other surgical specialty, there exists a fine line
between risk reduction for VTE and the potentially cata-
strophic implications for anticoagulation induced bleed-
ing. Considerable attention has been focused on this
topic but important gaps persist; the conclusion drawn
by Glotzbecker et al. echoed that of Catre a decade ear-
lier–the variability and inherent uncertainty regarding
thromboembolic practice reflects a shortage of robust,
scientific studies examining VTE in spinal surgery [13].
W h i l eg u i d a n c ee x i s t s ,f u r t her prospective controlled
research examining the epidemiology of VTE in spinal
surgery, the risk of bleeding complications and the
safety and efficacy of thromboprophylaxis regimes
[4,13-15] is required if substantive and acceptable guide-
lines–to which all practitioners adhere–are to be devel-
oped and put into clinical practice.
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